G935-2608 Screening compound: 2-(4-{[3-(2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-(pyrrolidin-1-yl)ethan-1-one

G935-2608 Screening compound: 2-(4-{[3-(2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-(pyrrolidin-1-yl)ethan-1-one
G935-2608 Screening compound: 2-(4-{[3-(2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-(pyrrolidin-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G935-2608
2-(4-{[3-(2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-(pyrrolidin-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G935-2608

Molecular Formula

C25H33N5O4S (C25 H33 N5 O4 S)

Compound Name

2-(4-{[3-(2,3-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-(pyrrolidin-1-yl)ethan-1-one

IUPAC name

2-(4-{[3-(23-dihydro-1H-indole-1-carbonyl)piperidin-1-yl]sulfonyl}-35-dimethyl-1H-pyrazol-1-yl)-1-(pyrrolidin-1-yl)ethan-1-one

SMILES

Cc(n(CC(N1CCCC1)=O)nc1C)c1S(N(CCC1)CC1C(N(CC1)c2c1cccc2)=O)(=O)=O

InChI

InChI=1S/C25H33N5O4S/c1-18-24(19(2)30(26-18)17-23(31)27-12-5-6-13-27)35(33,34)28-14-7-9-21(16-28)25(32)29-15-11-20-8-3-4-10-22(20)29/h3-4,8,10,21H,5-7,9,11-17H2,1-2H3/t21-/m0/s1

InChI Key

KQJBHTQRDAQAFA-NRFANRHFSA-N

MDL Number (MFCD)

MFCD27168174

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.63

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.171

Distribution Coefficient, logD

1.171

Water Solubility, LogSw

-2.33

Polar Surface Area

78.602

Acid Dissociation Constant (pKa)

21.14

Base Dissociation Constant (pKb)

-0.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

56.00

G935-2608 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G935-2608 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G935-2608?
Check Price and Availability of G935-2608, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G935-2608 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G935-2608
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G935-2608
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G935-2608 available by request